Click on headlines below to download research

Manager expects a reversal of recent results
The Biotech Growth Trust | 01/04/2022

The Biotech Growth Trust (BIOG) is managed by Geoff Hsu at healthcare specialist OrbiMed Capital, and benefits from OrbiMed’s presence in 11 offices…

Performance setback may provide an opportunity
The Biotech Growth Trust | 08/09/2021

The Biotech Growth Trust (BIOG) is managed by Geoff Hsu of OrbiMed Capital, which is a specialist healthcare investor with 11 offices across the globe…

Favourable industry fundamentals
The Biotech Growth Trust | 09/03/2021

The Biotech Growth Trust (BIOG) generated another year of positive absolute and relative performance in 2020. Manager Geoff Hsu of global specialist healthcare…